{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"FsJZJPEt1V\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/1326\/\">2008 \u5e74 11 \u6708 26 \u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/1326\/embed\/#?secret=FsJZJPEt1V\" width=\"600\" height=\"338\" title=\"\u201c\u300c2008\u5e7411\u670826\u65e5\u306e\u52d5\u7269\u306e\u5065\u5eb7\u306b\u95a2\u3059\u308b\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8\u300d\u2014 Brakke Consulting\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\" data-secret=\"FsJZJPEt1V\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"printer friendly version ******************************************************************* Brakke Consulting&#8217;s Animal Health News &amp; Notes for November 26, 2008 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS : &nbsp; earnings news Central Garden &amp; Pet Evialis &nbsp; other news AB Science Albion Alpharma Ascor Chimici Biopharm Boehringer Ingelheim Vetmedica BOMAC Vets Plus Dainippon Sumitomo Pharma IDEXX King Pharmaceuticals Modern Veterinary Therapeutics Nestle Purina Vetoquinol&nbsp; &nbsp; ******************************************************************* 2008 US FLEA CONTROL &amp; HEARTWORM MARKETS LAST DAY FOR EARLY-BIRD DISCOUNT IS NOV. 26! &nbsp; Contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com or 972-243-4033 to order or for more information. &nbsp; www.BrakkeConsulting.com &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt; Evialis has reported revenue of EUR 304 million ($439 million) for the first quarter of the 2008-2009 financial year ended September 30, an increase of nearly 64%. The increase reflected the high price of raw materials as well as the contribution of acquired businesses. On a like-for-like basis, revenue increased 26% over the previous year. (Animal Pharm) &nbsp; &gt; Central Garden &amp; Pet reported results for the fourth quarter ended September 27, 2008. Net sales for the Pet Products segment were $226 million, an increase of 2% compared to the year-ago period.&nbsp; (company website)&nbsp;&nbsp; &nbsp; ******************************************************************* COMPANY NEWS RELEASES &nbsp; &gt; King Pharmaceuticals, Inc. and Alpharma Inc. announced that the two companiesView Full Post;"}